Open AccessSacubitril/valsartan instead of renin‐angiotensin system inhibition alone: A step forward in resistant hypertension
Author(s) -
Stavropoulos Konstantinos,
Imprialos Konstantinos P.,
Doumas Michael
Publication year - 2018
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.13146
Subject(s) - neprilysin , medicine , sacubitril , valsartan , enalapril , heart failure , ejection fraction , bradykinin , angioedema , cardiology , pharmacology , angiotensin receptor , sacubitril, valsartan , blood pressure , angiotensin ii , angiotensin converting enzyme , receptor , biochemistry , chemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom